Back to Journals » Clinical Ophthalmology » Volume 4
RETRACTED ARTICLE: Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2
Authors Kernt M
, Neubauer AS, Eibl KH, Wolf A, Ulbig MW, Kampik A, Hirneiss C
Published 29 June 2010 Volume 2010:4 Pages 591—604
DOI https://doi.org/10.2147/OPTH.S11216
Review by Single anonymous peer review
Peer reviewer comments 3
This paper has been retracted.
Kernt M, Neubauer AS, Eibl KH, et al. Clin Ophthalmol. 2010;4:591–604. https://doi.org/10.2147/opth.s11216
We, the Editors and Publisher of the journal Clinical Ophthalmology, have retracted the published article.
After publication, concerns have been raised by a third party in 2025 about the integrity of the data in Figures 1 and 8 of the article. Further investigation conducted by the Journal and Publisher confirmed unusual similarities present in the image panels representative of different treatment conditions in Figure 1 and unexpected duplicate western blot bands in Figure 8.
When approached for an explanation, the authors did not respond to the queries raised by the Journal and Publisher.
As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
© 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
